Federici A B, Elder J H, De Marco L, Ruggeri Z M, Zimmerman T S
J Clin Invest. 1984 Dec;74(6):2049-55. doi: 10.1172/JCI111628.
To better define the role of carbohydrate in the structure and ristocetin cofactor activity of von Willebrand factor, we have removed up to 83% of total hexose by sequential treatment of the molecule with endo-beta-N-acetyl-glucosaminidase F (endo F), neuraminidase, and beta-galactosidase. Endo F alone removed 69% of total hexose and D-galactose, and 71% of sialic acid. However, there was no discernible loss of large multimers and the ristocetin cofactor activity was decreased by only 11%. The reduced von Willebrand factor subunit migrated more rapidly in polyacrylamide gels containing SDS, consistent with a 10% decrease of molecular mass. All multimers of unreduced carbohydrate-modified von Willebrand factor migrated more rapidly in SDS-agarose, but the triplet pattern of individual multimers was unchanged. This alteration in multimer migration rate did not resemble alterations found so far in von Willebrand disease variants. Further treatment of von Willebrand factor with neuraminidase and beta-galactosidase reduced the D-galactose to 15% and ristocetin cofactor activity to 57%. A similar decrease in ristocetin cofactor activity was seen if von Willebrand factor was treated only with neuraminidase and beta-galactosidase. In contrast, treating von Willebrand factor with neuraminidase and beta-galactosidase in the presence of protease inhibitors (20 mM benzamidine, 20 U/ml aprotonin, 15 micrograms/ml leupeptin) resulted in a comparable removal of carbohydrate with no change in ristocetin cofactor activity. Moreover, the multimeric structure remained intact in spite of 80% removal of D-galactose. This suggested that carbohydrate was protecting von Willebrand factor against traces of one or more protease contaminants. Evidence in support of this hypothesis was obtained by exposing von Willebrand factor to plasmin after pretreatment with neuraminidase alone or with neuraminidase and beta-galactosidase. A loss of large multimers was observed from von Willebrand factor that had been pretreated with neuraminidase, but this was even greater if pretreatment was also with beta-galactosidase. In contrast, the multimeric structure of von Willebrand factor with intact carbohydrate was not affected by plasmin under similar conditions. These studies suggest that carbohydrate protects von Willebrand factor from disaggregation occurring secondarily to proteolytic attack but does not play a direct role in maintaining its multimeric structure or ristocetin cofactor activity.
为了更明确碳水化合物在血管性血友病因子的结构和瑞斯托霉素辅因子活性中的作用,我们通过用内切β - N - 乙酰葡糖胺酶F(内切F)、神经氨酸酶和β - 半乳糖苷酶依次处理该分子,去除了高达83%的总己糖。单独使用内切F去除了69%的总己糖和D - 半乳糖,以及71%的唾液酸。然而,未观察到大分子多聚体有明显损失,瑞斯托霉素辅因子活性仅降低了11%。经碳水化合物修饰的血管性血友病因子亚基在含有十二烷基硫酸钠(SDS)的聚丙烯酰胺凝胶中迁移速度更快,这与分子量降低10%一致。未还原的碳水化合物修饰的血管性血友病因子的所有多聚体在SDS - 琼脂糖中迁移速度更快,但单个多聚体的三联体模式未改变。多聚体迁移速率的这种改变与迄今为止在血管性血友病疾病变体中发现的改变不同。用神经氨酸酶和β - 半乳糖苷酶进一步处理血管性血友病因子,使D - 半乳糖降至15%,瑞斯托霉素辅因子活性降至57%。如果仅用神经氨酸酶和β - 半乳糖苷酶处理血管性血友病因子,也会观察到类似的瑞斯托霉素辅因子活性降低。相反,在蛋白酶抑制剂(20 mM苯甲脒、20 U/ml抑肽酶、15 μg/ml亮抑肽酶)存在的情况下,用神经氨酸酶和β - 半乳糖苷酶处理血管性血友病因子,可去除相当量的碳水化合物,而瑞斯托霉素辅因子活性无变化。此外,尽管去除了80%的D - 半乳糖,多聚体结构仍保持完整。这表明碳水化合物可保护血管性血友病因子免受一种或多种蛋白酶污染物痕迹的影响。通过单独用神经氨酸酶或用神经氨酸酶和β - 半乳糖苷酶预处理后将血管性血友病因子暴露于纤溶酶,获得了支持这一假设的证据。在用神经氨酸酶预处理的血管性血友病因子中观察到大分子多聚体的损失,但如果也用β - 半乳糖苷酶预处理,这种损失会更大。相反,在类似条件下,碳水化合物完整的血管性血友病因子的多聚体结构不受纤溶酶影响。这些研究表明,碳水化合物可保护血管性血友病因子免受蛋白水解攻击继发的解聚作用,但在维持其多聚体结构或瑞斯托霉素辅因子活性方面不发挥直接作用。